US FDA Expands Approval of Amgen’s Repatha, Offering Millions of Adults at Risk of Heart Disease Wider Access to a Breakthrough Cholesterol-Lowering Therapy
By Team VOH
Amgen announced that the U.S. Food and Drug Administration (FDA) has expanded